Clinical trials are a very important part of the research process. New treatments, medications and medical devices cannot be approved for use in Australia without going through clinical trials. Find out more about clinical trials.
Tirzepatide for people with type 2 diabetes
A clinical trial investigating the safety and effectiveness of tirzepatide taken once weekly compared to insulin taken once daily in people with type 2 diabetes and increased cardiovascular risk.
This study is testing a potential new treatment called donanemab (also known as LY3002813) for people with early Alzheimer’s Disease.
A pre-screening study to find eligible participants for future clinical trials that test new drugs for Alzheimer’s disease.
Treatment for moderately to severely active ulcerative colitis
A clinical trial to assess whether guselkumab and golimumab when used together is safe and effective for treating participants with moderately to severely active ulcerative colitis (UC).
Trial to assess a new tablet for plaque psoriasis
Plaque psoriasis is an autoimmune condition characterised by dry, itchy and scaly skin patches. This trial investigates whether people with plaque psoriasis may be able to take an oral treatment to improve the condition.
Type1Screen: Diabetes autoantibody screening to identify individuals at risk for type 1 diabetes
An observational study to try and identify people at risk of developing type 1 diabetes
Understanding antigen triggers in psoriasis
A non-interventional study to investigate triggers in psoriasis.
Vagus nerve stimulation (VNS) device for the treatment of epilepsy
This post-market study involves collecting information for an already approved VNS device to get detailed information about the outcomes of people receiving the approved treatment.
WVE-003 in patients with Huntington’s disease
A multicentre, randomised, double-blind, placebo-controlled, phase 1b/2a study of WVE-003 in patients with Huntington’s disease.